Breaking News Instant updates and real-time market news.

VSLR

Vivint Solar

$4.35

0.35 (8.75%)

, RUN

Sunrun

$5.85

0.11 (1.92%)

05:31
06/20/17
06/20
05:31
06/20/17
05:31

Vivint Solar upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Brian Lee upgraded Vivint Solar to Buy citing the potential for increased mergers and acquisitions in the U.S. solar sector. The analyst raised his price target for the shares to $6 from $3.50. Lee assigned Vivint Goldman's highest M&A rank of 1 and sees increased restructuring potential in the residential solar business. The analyst also raised his price targets for Buy-rated Sunrun (SUN) to $10 and Buy-rated 8point3 Energy (CAFD) to $16.

VSLR

Vivint Solar

$4.35

0.35 (8.75%)

RUN

Sunrun

$5.85

0.11 (1.92%)

CAFD

8point3 Energy

$13.70

0.2 (1.48%)

  • 20

    Jun

VSLR Vivint Solar
$4.35

0.35 (8.75%)

03/17/17
JMPS
03/17/17
NO CHANGE
JMPS
Vivint Solar 'making solid progress,' says JMP Securities
After Vivint Solar reported a lower than expected EPS loss but missed slightly on the top line, JMP Securities analyst Joseph Osha says that the company "is making solid progress" with its rebuilding process. The analyst says that the company has sufficient financing to continue its business for at least another two quarters. He thinks that the stock could be worth $11 per share, but he says that the company's business environment is "very unstable," and he keeps a Market Perform rating on the shares.
11/10/16
JMPS
11/10/16
DOWNGRADE
JMPS
Market Perform
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
10/07/16
10/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying the company's near-to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. 2. DuPont Fabros (DFT) upgraded to Buy from Hold at Stifel with analyst Matthew Heinz saying the company's current valuation reflects an expectation for weaker Q3 leasing activity. 3. Ralph Lauren (RL) upgraded to Conviction Buy from Buy at Goldman with analyst Lindsay Drucker Mann saying CEO Stefan Larsson's turnaround is firmly in place. 4. Restoration Hardware (RH) upgraded to Neutral from Underperform at Buckingham with the firm's analyst believing $1.60-$1.80 fiscal 2016 earnings are achievable, reducing the risk of further downward earnings revisions. 5. Vivint Solar (VSLR) upgraded to Neutral from Sell at Goldman with analyst Brian Lee saying the company is "moving on the path toward recovery." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
GSCO
10/06/16
UPGRADE
GSCO
Neutral
Vivint Solar upgraded to Neutral from Sell at Goldman
Goldman analyst Brian Lee upgraded Vivint to Neutral from Sell with a $3.50 price target, saying the company is "moving on the path toward recovery."
RUN Sunrun
$5.85

0.11 (1.92%)

11/22/16
LEHM
11/22/16
UPGRADE
Target $7
LEHM
Overweight
Sunrun upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Jon Windham upgraded Sunrun (RUN) to Overweight following the company's Q3 results with an unchanged price target of $7. The analyst sees potential for the company to take market share given the expected scaled-back operations at SolarCity following completion of the merger with Tesla (TSLA). A significant amount of negative sentiment has been priced into Sunrun with the stock down 25% over the last month, Windham tells investors in a research note.
11/22/16
11/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Charles Schwab (SCHW) upgraded to Buy from Neutral at Citi with analyst William Katz citing the company's leverage to interest rates and its potential earnings power in 2018. 2. DTE Energy (DTE) upgraded to Buy from Neutral at BofA Merrill Lynch with analyst Brian Chin saying he believes DTE's Gas Storage and Pipeline net income will benefit under a Trump presidency. 3. Cooper-Standard (CPS) upgraded to Buy from Neutral at Goldman with analyst David Tamberrino saying valuation is not capturing operating improvements, incremental footprint restructuring activities, and significant growth in China. 4. GoDaddy (GDDY) upgraded to Buy from Neutral at B. Riley with analyst Sameet Sinha citing more confidence in the company's growth metrics. 5. Sunrun (RUN) upgraded to Overweight from Equal Weight at Barclays with analyst Jon Windham saying he sees potential for the company to take market share given the expected scaled-back operations at SolarCity following completion of the merger with Tesla (TSLA). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/22/17
UBSW
03/22/17
UPGRADE
Target $6.5
UBSW
Buy
Sunrun upgraded to Buy from Neutral at UBS
UBS analyst Julien Dumoulin-Smith upgraded Sunrun to Buy citing accelerating prospects amid policy support in the Northeast. States in the Northeast are "becoming the new home" for the company's growth, Dumoulin-Smith tells investors in a research note. The analyst has a $6.50 price target for the shares.
03/22/17
03/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyBanc analyst Todd Thomas upgraded Urban Outfitters (URBN) to Overweight from Sector Weight, saying the retailer has a highly differentiated product offering and has made significant investments to capture e-commerce share. 2. Deutsche Bank analyst Rod Lache upgraded BorgWarner (BWA) to Buy from Hold, saying the prospects for business units focused on Internal Combustion efficiency and emissions are better than he previously thought. The analyst expects penetration of battery electric vehicles will remain "relatively low" through the 2020s. He raised his price target for BorgWarner shares to $51 from $41. The analyst this morning also raised his price target for Buy-rated Delphi (DLPH) to $99 from $88 and Hold-rated Tenneco (TEN) to $78 from $75. 3. UBS analyst Julien Dumoulin-Smith upgraded Sunrun (RUN) to Buy from Neutral, citing accelerating prospects amid policy support in the Northeast. 4. Wedbush analyst Henry Coffey upgraded LendingClub (LC) to Neutral from Underperform, saying management has made a very good case in recent meetings on how they will enhance the breadth of the marketplace and grow volumes. 5. Credit Suisse analyst Andre Natal upgraded Petrobras (PBR) to Outperform with an $11 price target saying recent share weakness provides a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CAFD 8point3 Energy
$13.70

0.2 (1.48%)

06/14/17
GUGG
06/14/17
DOWNGRADE
GUGG
Neutral
8point3 Energy downgraded to Neutral from Buy at Guggenheim
Guggenheim downgraded 8point3 Energy to Neutral citing valuation.
06/14/17
GUGG
06/14/17
DOWNGRADE
GUGG
Neutral
8point3 Energy downgraded to Neutral from Buy at Guggenheim
04/11/17
FBRC
04/11/17
DOWNGRADE
Target $13
FBRC
Market Perform
8point3 Energy downgraded to Market Perform from Outperform at FBR Capital
FBR Capital analyst Carter Driscoll downgraded 8point3 Energy 8point3 Energy citing sponsorship uncertainties after First Solar (FSLR) pursuing strategic alternatives for its interest. The analyst lowered his price target for the shares to $13 from $15.
04/06/17
04/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. T-Mobile (TMUS) downgraded to Hold from Buy at Deutsche Bank with analyst Matthew Niknam saying the risk/reward is more balanced at current levels amid intensifying competition in U.S. wireless. The analyst sees "limited incremental upside" from M&A scenarios and keeps a $68 price target for the shares. 2. Jazz Pharmaceuticals (JAZZ) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying the Xyrem generics will not reach the market ahead of prior expectations and lowered its price target to $150 from $162 saying the model fully credits other products and pipeline. 3. Ultragenyx (RARE) downgraded to Hold from Buy at Jefferies with analyst Brian Abrahams saying he sees potential headwinds as the company builds into small/less well-defined markets and believes the stock at current levels is fairly valued. 4. Bunge (BG) downgraded to Underweight from Neutral at JPMorgan with analyst Ann Duignan saying execution risks appear skewed to the downside in the near-term while "conditions conducive to a sale of sugar assets seem to have eroded in recent weeks." The analyst keeps a $70 price target for the shares. 5. 8point3 Energy (CAFD) was downgraded to Neutral from Buy at BofA/Merrill and Janney Capital, to Perform from Outperform at Oppenheimer, and to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

PAM

Pampa Energia S.A.

$60.93

0.2 (0.33%)

07:48
09/19/17
09/19
07:48
09/19/17
07:48
Initiation
Pampa Energia S.A. initiated  »

Pampa Energia S.A. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Breaking Hot Stocks news story on Progress Software »

Progress:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Progress Software 'values' Praesidium's ideas, welcomes input from investors »

In response to a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

, AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Hot Stocks
Jacobs Engineering selected by Aerie Pharmaceuticals as engineering contractor »

Jacobs Engineering Group…

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

  • 28

    Feb

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

, AXAHY

AXA

$29.47

0.13 (0.44%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Periodicals
BNP weighing tie-up of money-management division with Axa unit, Bloomberg says »

BNP Paribas (BNPQY),…

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

AXAHY

AXA

$29.47

0.13 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHFC

Chemical Financial

$49.32

0.71 (1.46%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Downgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSII

Quality Systems

$15.71

-0.14 (-0.88%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Initiation
Quality Systems initiated  »

Quality Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
09/19/17
09/19
07:45
09/19/17
07:45
General news
N.Y. FX Outlook »

N.Y. FX Outlook: Risk-on…

HOLI

Hollysys

$20.77

0.42 (2.06%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Conference/Events
Hollysys management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 16

    Oct

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

KORS

Michael Kors

$44.65

-0.27 (-0.60%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Technical Analysis
Technical View: Michael Kors moves higher, analyst action »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Periodicals
Intel Capital invested over $1B in AI-focused companies, TechCrunch says »

Intel has invested more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 05

    Oct

PDCO

Patterson Companies

$37.94

-0.59 (-1.53%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Initiation
Patterson Companies initiated  »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$179.98

3.28 (1.86%)

, BSTI

BEST Inc

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Syndicate
BEST Inc cuts size of proposed IPO following 'tepid' response, Reuters reports »

Best Inc (BSTI), a…

BABA

Alibaba

$179.98

3.28 (1.86%)

BSTI

BEST Inc

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FOLD

Amicus

$13.67

-0.21 (-1.51%)

07:42
09/19/17
09/19
07:42
09/19/17
07:42
Hot Stocks
Amicus granted FDA Fast Track Designation for migalastat »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.73

0.1 (3.80%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Initiation
Rite Aid initiated  »

Rite Aid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.